Journal Reviews

Orbit journal cover

Ophthalmic presentations and outcomes in Erdheim-Chester disease

4 December 2023 | | Oculoplastics, Orbit | Erdheim–Chester disease, orbital Erdheim–Chester disease, vemurafenib

This is a comprehensive article describing clinical manifestations and pathogenesis of Erdheim-Chester disease (ECD) followed by a literature review of the available treatments. The authors look to compare historical treatment (HT) with vemurafenib, a BRAF inhibitor. ECD is a non-Langerhans...